Mereo BioPharma

Ultragenyx-Mereo's brittle bone drug sustains fracture rate cut in midphase follow-up
Fierce Biotech
Wed, 06/12/24 - 11:49 am
Ultragenyx
Mereo BioPharma
brittle bone disease
clincial trials
setrusumab
Activist investor snaps Mereo's olive branch as proxy feud looms
Fierce Biotech
Mon, 09/26/22 - 10:37 am
Mereo BioPharma
activists
Rumor mill says AstraZeneca may be eyeing a takeover of Mereo
Pharmaforum
Fri, 06/17/22 - 10:41 am
AstraZeneca
Mereo BioPharma
M&A
Asset resuscitation fails to resuscitate Mereo
EP Vantage
Tue, 05/10/22 - 10:35 am
Mereo BioPharma
alpha 1-antitrypsin deficiency
Biotech Mereo BioPharma pens $50M Ultragenyx deal for rare bone disease drug
Fierce Biotech
Fri, 12/18/20 - 11:41 am
Mereo BioPharma
Ultragenyx
setrusumab
osteogenesis imperfecta
Newly merged Mereo BioPharma looks to OncoMed for R&D hires
Fierce Biotech
Tue, 06/30/20 - 10:35 am
Mereo BioPharma
IPOs
OncoMed
R&D
Mereo’s brittle bone drug likely to shrug off phase 2b fail, say analysts
Pharmaforum
Sat, 11/30/19 - 11:01 pm
Mereo BioPharma
clinical trials
brittle bone disease
setrusumab
UK biotech Mereo gears up for key brittle bone drug data
Pharmaforum
Thu, 05/2/19 - 11:15 am
Mereo BioPharma
brittle bone disease
osteogenesis imperfecta
setrusumab
Mereo BioPharma, OncoMed agree to merge
Pharmaceutical Business Review
Thu, 12/6/18 - 09:57 am
M&A
Mereo BioPharma
OncoMed
AstraZeneca hands Mereo rights to lung drug
BioPharma Dive
Mon, 10/30/17 - 11:23 pm
AstraZeneca
Mereo BioPharma
AZD9668
Novartis swaps mid-stage compounds for equity stake in start-up Mereo BioPharma
First Word Pharma
Wed, 07/29/15 - 12:42 pm
Novartis
Mereo BioPharma